Discontinued
Low Outlier
DEA Schedule CII

Strength

1.25; 1.25; 1.25; 1.25 mg/1; mg/1; mg/1; mg/1

NDC

00527551037

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

11/19/2025

Approval Type

Generic (ANDA)

FDA Application

ANDA212037

On Market Since

12/18/2019

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-5.7%

1Y

-16.4%

3Y

-38.3%

5Y

-42.7%

All

-49.4%